Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Vestre Viken Hospital Trust
Information provided by (Responsible Party):
Vestre Viken Hospital Trust Identifier:
First received: October 31, 2012
Last updated: June 29, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)